Free Trial

Greenleaf Trust Has $18.12 Million Stake in Procter & Gamble Company (The) (NYSE:PG)

Procter & Gamble logo with Consumer Staples background

Greenleaf Trust decreased its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 1.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 106,348 shares of the company's stock after selling 1,735 shares during the period. Greenleaf Trust's holdings in Procter & Gamble were worth $18,124,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the stock. Norges Bank purchased a new stake in Procter & Gamble during the 4th quarter worth $5,244,463,000. GAMMA Investing LLC grew its stake in shares of Procter & Gamble by 20,758.5% during the first quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock valued at $1,355,087,000 after acquiring an additional 7,913,335 shares in the last quarter. Capital Research Global Investors increased its position in shares of Procter & Gamble by 62.5% during the fourth quarter. Capital Research Global Investors now owns 7,398,120 shares of the company's stock worth $1,240,294,000 after acquiring an additional 2,846,560 shares during the last quarter. Northern Trust Corp lifted its stake in shares of Procter & Gamble by 10.1% in the fourth quarter. Northern Trust Corp now owns 29,395,208 shares of the company's stock worth $4,928,107,000 after acquiring an additional 2,703,757 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Procter & Gamble by 15.8% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company's stock valued at $2,728,430,000 after purchasing an additional 2,224,912 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.

Insider Buying and Selling at Procter & Gamble

In other news, insider Moses Victor Javier Aguilar sold 10,520 shares of the company's stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $158.67, for a total value of $1,669,208.40. Following the transaction, the insider owned 25,182 shares in the company, valued at $3,995,627.94. This represents a 29.47% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Jennifer L. Davis sold 1,000 shares of the firm's stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total transaction of $161,380.00. Following the sale, the chief executive officer owned 51,965 shares of the company's stock, valued at approximately $8,386,111.70. This represents a 1.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.18% of the company's stock.

Procter & Gamble Price Performance

Procter & Gamble stock traded down $0.53 during mid-day trading on Wednesday, hitting $157.36. The company's stock had a trading volume of 18,769,238 shares, compared to its average volume of 7,565,889. Procter & Gamble Company has a twelve month low of $155.98 and a twelve month high of $180.43. The stock's fifty day moving average price is $161.98 and its two-hundred day moving average price is $165.15. The stock has a market capitalization of $368.94 billion, a P/E ratio of 24.98, a P/E/G ratio of 4.57 and a beta of 0.40. The company has a quick ratio of 0.50, a current ratio of 0.71 and a debt-to-equity ratio of 0.47.

Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The company reported $1.54 earnings per share for the quarter, beating analysts' consensus estimates of $1.53 by $0.01. Procter & Gamble had a return on equity of 32.67% and a net margin of 18.46%. The business had revenue of $19.78 billion during the quarter, compared to analyst estimates of $20.42 billion. During the same quarter last year, the company posted $1.52 EPS. Procter & Gamble's revenue for the quarter was down 2.1% on a year-over-year basis. Research analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be paid a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.69%. The ex-dividend date of this dividend is Friday, July 18th. Procter & Gamble's dividend payout ratio (DPR) is currently 67.14%.

Analyst Upgrades and Downgrades

PG has been the topic of a number of recent analyst reports. Truist Financial cut their target price on shares of Procter & Gamble from $185.00 to $180.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. Piper Sandler raised their price target on shares of Procter & Gamble from $160.00 to $164.00 and gave the stock a "neutral" rating in a research report on Monday, May 5th. Erste Group Bank downgraded Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 30th. Royal Bank Of Canada raised Procter & Gamble from a "sector perform" rating to an "outperform" rating and raised their price target for the stock from $164.00 to $177.00 in a report on Friday, April 25th. Finally, Barclays reiterated an "equal weight" rating on shares of Procter & Gamble in a research note on Thursday, March 27th. Eight equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $178.45.

Get Our Latest Stock Analysis on Procter & Gamble

Procter & Gamble Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Stories

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines